Vanguard Personalized Indexing Management LLC Boosts Holdings in Waters Co. (NYSE:WAT)

Vanguard Personalized Indexing Management LLC grew its stake in shares of Waters Co. (NYSE:WATFree Report) by 8.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,942 shares of the medical instruments supplier’s stock after buying an additional 321 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Waters were worth $1,081,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Glassman Wealth Services raised its position in Waters by 39.6% during the second quarter. Glassman Wealth Services now owns 141 shares of the medical instruments supplier’s stock valued at $38,000 after purchasing an additional 40 shares in the last quarter. Private Trust Co. NA boosted its stake in Waters by 55.3% in the third quarter. Private Trust Co. NA now owns 118 shares of the medical instruments supplier’s stock worth $32,000 after buying an additional 42 shares in the last quarter. Summit Trail Advisors LLC grew its position in Waters by 3.9% during the third quarter. Summit Trail Advisors LLC now owns 1,180 shares of the medical instruments supplier’s stock valued at $324,000 after acquiring an additional 44 shares during the last quarter. IFP Advisors Inc raised its stake in shares of Waters by 35.2% during the third quarter. IFP Advisors Inc now owns 173 shares of the medical instruments supplier’s stock worth $47,000 after acquiring an additional 45 shares in the last quarter. Finally, Wetherby Asset Management Inc. lifted its holdings in shares of Waters by 2.9% in the 1st quarter. Wetherby Asset Management Inc. now owns 1,645 shares of the medical instruments supplier’s stock worth $511,000 after acquiring an additional 46 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Waters Stock Down 1.2 %

NYSE WAT opened at $322.82 on Monday. The business’s 50-day moving average is $315.13 and its 200 day moving average is $285.33. The stock has a market capitalization of $19.09 billion, a PE ratio of 29.75, a PEG ratio of 6.42 and a beta of 0.92. The company has a debt-to-equity ratio of 2.71, a current ratio of 0.69 and a quick ratio of 0.47. Waters Co. has a 1 year low of $231.90 and a 1 year high of $341.94.

Waters (NYSE:WATGet Free Report) last posted its earnings results on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.56 by $0.06. Waters had a return on equity of 81.30% and a net margin of 21.72%. The firm had revenue of $819.50 million for the quarter, compared to analysts’ expectations of $815.50 million. During the same period in the previous year, the firm earned $3.84 earnings per share. The business’s revenue was down 4.5% compared to the same quarter last year. Sell-side analysts forecast that Waters Co. will post 11.89 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Stifel Nicolaus increased their target price on shares of Waters from $290.00 to $330.00 and gave the company a “hold” rating in a report on Wednesday, February 7th. Wells Fargo & Company decreased their price objective on Waters from $305.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 8th. JPMorgan Chase & Co. lowered their target price on Waters from $260.00 to $250.00 and set a “neutral” rating for the company in a research note on Wednesday, November 8th. TheStreet upgraded Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. Finally, Citigroup lifted their price target on Waters from $265.00 to $300.00 and gave the stock a “neutral” rating in a research note on Monday, December 11th. One analyst has rated the stock with a sell rating and eight have issued a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $290.38.

Read Our Latest Analysis on WAT

About Waters

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.